Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

TOPOTECAN HYDROCHLORIDE

TOPOTECAN HYDROCHLORIDE

Standard Dose
EQ 4MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TOPOTECAN HYDROCHLORIDE is listed in Drugs@FDA under application 206962 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TOPOTECAN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 4MG BASE/VIAL Sponsor INGENUS PHARMS LLC Submission history Latest submission status date: 2024-02-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview TOPOTECAN HYDROCHLORIDE is listed in Drugs@FDA under application 206962 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TOPOTECAN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 4MG BASE/VIAL Sponsor INGENUS PHARMS LLC Submission history Latest submission status date: 2024-02-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.